111 related articles for article (PubMed ID: 11698280)
21. The Use of Blood Biomarkers in Precision Medicine for the Primary Prevention of Atherosclerotic Cardiovascular Disease: a Review.
Sweeney T; Quispe R; Das T; Juraschek SP; Martin SS; Michos ED
Expert Rev Precis Med Drug Dev; 2021; 6(4):247-258. PubMed ID: 34423130
[TBL] [Abstract][Full Text] [Related]
22. Associations of Genetically Predicted Lp(a) (Lipoprotein [a]) Levels With Cardiovascular Traits in Individuals of European and African Ancestry.
Satterfield BA; Dikilitas O; Safarova MS; Clarke SL; Tcheandjieu C; Zhu X; Bastarache L; Larson EB; Justice AE; Shang N; Rosenthal EA; Shah AS; Namjou-Khales B; Urbina EM; Wei WQ; Feng Q; Jarvik GP; Hebbring SJ; de Andrade M; Manolio TA; Assimes TL; Kullo IJ
Circ Genom Precis Med; 2021 Aug; 14(4):e003354. PubMed ID: 34282949
[TBL] [Abstract][Full Text] [Related]
23. Relationship between lipoproteins, thrombosis, and atrial fibrillation.
Ding WY; Protty MB; Davies IG; Lip GYH
Cardiovasc Res; 2022 Feb; 118(3):716-731. PubMed ID: 33483737
[TBL] [Abstract][Full Text] [Related]
24. The role of Lipoprotein(a) in cardiovascular disease: Current concepts and future perspectives.
Vavuranakis MA; Jones SR; Cardoso R; Gerstenblith G; Leucker TM
Hellenic J Cardiol; 2020; 61(6):398-403. PubMed ID: 33039574
[TBL] [Abstract][Full Text] [Related]
25. Lipoprotein(a) and Its Potential Association with Thrombosis and Inflammation in COVID-19: a Testable Hypothesis.
Moriarty PM; Gorby LK; Stroes ES; Kastelein JP; Davidson M; Tsimikas S
Curr Atheroscler Rep; 2020 Jul; 22(9):48. PubMed ID: 32710255
[TBL] [Abstract][Full Text] [Related]
26. Atherogenic Lipoprotein(a) Increases Vascular Glycolysis, Thereby Facilitating Inflammation and Leukocyte Extravasation.
Schnitzler JG; Hoogeveen RM; Ali L; Prange KHM; Waissi F; van Weeghel M; Bachmann JC; Versloot M; Borrelli MJ; Yeang C; De Kleijn DPV; Houtkooper RH; Koschinsky ML; de Winther MPJ; Groen AK; Witztum JL; Tsimikas S; Stroes ESG; Kroon J
Circ Res; 2020 May; 126(10):1346-1359. PubMed ID: 32160811
[TBL] [Abstract][Full Text] [Related]
27. Lipoprotein(a) the Insurgent: A New Insight into the Structure, Function, Metabolism, Pathogenicity, and Medications Affecting Lipoprotein(a) Molecule.
Jawi MM; Frohlich J; Chan SY
J Lipids; 2020; 2020():3491764. PubMed ID: 32099678
[TBL] [Abstract][Full Text] [Related]
28. Potent reduction of plasma lipoprotein (a) with an antisense oligonucleotide in human subjects does not affect ex vivo fibrinolysis.
Boffa MB; Marar TT; Yeang C; Viney NJ; Xia S; Witztum JL; Koschinsky ML; Tsimikas S
J Lipid Res; 2019 Dec; 60(12):2082-2089. PubMed ID: 31551368
[TBL] [Abstract][Full Text] [Related]
29. Serum lipoprotein(a) and risk of hemorrhagic stroke among incident peritoneal dialysis patients: a large study from a single center in China.
Chen Y; Zhan X; Zhao Q; Wei X; Xiao J; Yan C; Zhang W
Ren Fail; 2019 Nov; 41(1):800-807. PubMed ID: 31498021
[No Abstract] [Full Text] [Related]
30. Investigating the Atherogenic Risk of Lipoprotein(a) in Type 2 Diabetic Patients.
Peela JR; Latiwesh OB; Elshaari F; Hussain A; Tabrez E; Viglianco E; Edwards A; Ali F; Rawal AK
Cureus; 2018 Jul; 10(7):e3030. PubMed ID: 30254819
[TBL] [Abstract][Full Text] [Related]
31. Associations of Lipoprotein(a) Levels With Incident Atrial Fibrillation and Ischemic Stroke: The ARIC (Atherosclerosis Risk in Communities) Study.
Aronis KN; Zhao D; Hoogeveen RC; Alonso A; Ballantyne CM; Guallar E; Jones SR; Martin SS; Nazarian S; Steffen BT; Virani SS; Michos ED
J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29246963
[TBL] [Abstract][Full Text] [Related]
32. [Multiple thrombophilic risk markers in patients ≺65 years of age with retinal vein occlusion].
Kuhli-Hattenbach C; Hellstern P; Miesbach W; Kohnen T; Hattenbach LO
Ophthalmologe; 2017 Dec; 114(12):1149-1154. PubMed ID: 28185002
[TBL] [Abstract][Full Text] [Related]
33. Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.
Nordestgaard BG; Langsted A
J Lipid Res; 2016 Nov; 57(11):1953-1975. PubMed ID: 27677946
[TBL] [Abstract][Full Text] [Related]
34. Effect of Two Lipoprotein (a)-Associated Genetic Variants on Plasminogen Levels and Fibrinolysis.
Wang H; Hong CE; Lewis JP; Zhu Y; Wang X; Chu X; Backman J; Hu Z; Yang P; Still CD; Gerhard GS; Fu M
G3 (Bethesda); 2016 Nov; 6(11):3525-3532. PubMed ID: 27605514
[TBL] [Abstract][Full Text] [Related]
35. Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?
Boffa MB; Koschinsky ML
J Lipid Res; 2016 May; 57(5):745-57. PubMed ID: 26647358
[TBL] [Abstract][Full Text] [Related]
36. Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study.
Ashrani AA; Barsoum MK; Crusan DJ; Petterson TM; Bailey KR; Heit JA
Thromb Res; 2015 Jun; 135(6):1110-6. PubMed ID: 25891841
[TBL] [Abstract][Full Text] [Related]
37. Lipoprotein(a) hyperlipidemia as cardiovascular risk factor: pathophysiological aspects.
Schmitz G; Orsó E
Clin Res Cardiol Suppl; 2015 Apr; 10(Suppl 1):21-5. PubMed ID: 25708587
[TBL] [Abstract][Full Text] [Related]
38. Evidence for several independent genetic variants affecting lipoprotein (a) cholesterol levels.
Lu W; Cheng YC; Chen K; Wang H; Gerhard GS; Still CD; Chu X; Yang R; Parihar A; O'Connell JR; Pollin TI; Angles-Cano E; Quon MJ; Mitchell BD; Shuldiner AR; Fu M
Hum Mol Genet; 2015 Apr; 24(8):2390-400. PubMed ID: 25575512
[TBL] [Abstract][Full Text] [Related]
39. The expanding role of lipoprotein apheresis in the treatment of raised lipoprotein(a) in ischaemic heart disease and refractory angina.
Khan TZ; Pottle A; Pennell DJ; Barbir MS
Glob Cardiol Sci Pract; 2014; 2014(1):3-12. PubMed ID: 25054114
[TBL] [Abstract][Full Text] [Related]
40. LPA rs10455872 polymorphism is associated with coronary lesions in Brazilian patients submitted to coronary angiography.
Santos PC; Bueno CT; Lemos PA; Krieger JE; Pereira AC
Lipids Health Dis; 2014 Apr; 13():74. PubMed ID: 24776095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
